Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02810704 · ClinicalTrials.gov registry record · Phase 4
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
A Phase 4 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 18,883
- Enrollment target
NCT02810704 is a Phase 4 study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 18,883 participants.
The verdict
NCT02810704, a Phase 4 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18,883 participants
- Enrollment target
Study Summary
PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban.
Interventions
- DRUG Warfarin
- DRUG Rivaroxaban
- DRUG Enteric Coated Aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,883 participants |
| Start Date | 2016-12 |
| Est. Completion | 2025-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02810704
The ClinicalTrials.gov registry entry for NCT02810704 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 18,883 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Warfarin is the first listed.
NCT02810704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02810704 about?
NCT02810704 is a clinical study titled "Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement". PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban...
What is the current status of trial NCT02810704?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18,883 participants. The study started on 2016-12. Estimated completion is 2025-09.
What interventions are being tested in trial NCT02810704?
The interventions under investigation include: Warfarin (DRUG), Rivaroxaban (DRUG), Enteric Coated Aspirin (DRUG).
Who is sponsoring clinical trial NCT02810704?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.